Successful Completion of Phase I/IIa Clinical Study of VAC-3S Immunotherapeutic Vaccine

News   Dec 03, 2012

 
Successful Completion of Phase I/IIa Clinical Study of VAC-3S Immunotherapeutic Vaccine
 
 
 

RELATED ARTICLES

Consuming Sugary Drinks During Pregnancy May Increase Asthma Risk in Mid-Childhood

News

Children between the ages of 7 and 9 may be at greater risk for developing asthma if they consumed high amounts of fructose in early childhood or their mothers drank a lot of sugar-sweetened beverages while pregnant, according to new research.

READ MORE

Probiotic Gets a Boost from Breast Milk

News

Supplementation with probiotics can improve a person's gut health, but the benefits are often fleeting, and colonization by the probiotic's good microbes usually doesn't last. Breast milk may help sustain those colonies in the long run.

READ MORE

Immune Response Restored in Patients with Melanoma Thanks to New Compound

News

A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE